Vet Ventures Europe - Company finances
|
EUR
|
2021
From: 2021-12-07
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | - | - | - | 347,527 | 441,136 |
| Profit before tax | - | - | - | - | - |
| Net profit | -5,864 | -147,648 | -388,309 | -438,517 | -546,917 |
| Equity | -3,364 | 3,919,414 | 3,531,105 | 3,092,588 | 2,545,670 |
| Liabilities | 5,864 | 2,783,804 | 7,846,903 | 9,760,153 | 11,581,880 |
| Non-current assets | 0 | 2,992,425 | 11,059,536 | 12,836,639 | 13,900,134 |
| Current assets | 2,500 | 3,710,793 | 318,372 | 16,009 | 227,317 |
| Total assets | 2,500 | 6,703,218 | 11,377,908 | 12,852,648 | 14,127,451 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 9,479 | 68,496 | 84,681 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | - | - | +26.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -234.6% | -2.2% | -3.4% | -3.4% | -3.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | -3.8% | -11.0% | -14.2% | -21.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | -126.2% | -124.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.7 | 2.2 | 3.2 | 4.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | 173,764 | 220,568 |
Sales revenue
Consolidated Vet Ventures Europe finance
|
EUR
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|
|
Financial data
|
|
| Sales revenue | 13,925,854 |
| Profit before tax | -3,094,546 |
| Net profit | -2,822,619 |
| Equity | -5,859,601 |
| Liabilities | 14,481,662 |
| Non-current assets | 6,973,341 |
| Current assets | 1,679,363 |
| Total assets | 8,652,704 |
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vet Ventures Europe - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-06-08 | 2025-06-09 | 2.24 |
| 2025-05-16 | 2025-06-04 | 2.24 |
| 2025-05-04 | 2025-05-13 | 2.24 |
| 2025-04-24 | 2025-04-29 | 2.24 |
| 2025-01-16 | 2025-01-23 | 921.37 |
| 2023-04-18 | 2023-04-19 | 825.79 |
| 2022-10-18 | 2022-10-19 | 96.12 |
| 2022-05-17 | 2022-05-24 | 48.84 |
| 2022-04-28 | 2022-05-16 | 0.30 |
| 2022-03-16 | 2022-03-30 | 48.54 |
| 2022-02-17 | 2022-02-28 | 15.29 |
Vet Ventures Europe - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-09-28 | 2025-10-18 | 0.32 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vet Ventures Europe, UAB (code 305949929) is a Private Limited Liability Company engaged in activities of holding companies. In 2025, revenue increased by 26.9% to €441.1K, but the company still reported a net loss of €546.9K, compared with a loss of €438.5K in 2024 and €388.3K in 2023. The profit margin in 2025 was -124.0%, showing that operating income remained insufficient to cover costs. Over the three-year period, profitability weakened while revenue expanded from the 2024 base. Total assets rose to €14.13M in 2025 from €12.85M in 2024 and €11.38M in 2023, with long-term assets accounting for most of the balance sheet at €13.90M. Equity declined to €2.55M, while liabilities increased to €11.58M. The company’s key ratios indicate limited efficiency and weak returns: ROE was -21.5%, ROA -3.9%, debt-to-equity 4.55, and asset turnover 0.03x. Revenue per employee was €220.6K, indicating relatively high turnover per employee despite negative profitability.